| 英文名称 |
中文名称 |
CAS号 |
操作 |
| (R)-Metomidate |
依托咪酯杂质 |
61045-91-8 |
详细
|
| Etomidate EP Impurity A |
依托咪酯杂质A |
3157-27-5 |
详细
|
| MMRi62 |
7-((2,3-二氯苯基)(吡啶-2-基氨基)甲基)喹啉-8-醇 |
352693-80-2 |
详细
|
| TUG-469 |
TUG-469 |
1236109-67-3 |
详细
|
| LRE1 |
化合物 T15787 |
1252362-53-0 |
详细
|
| Benzenepropanoicacid |
3,5-二(叔丁基)-4-羟基-苯丙酸,3-羟基-2,2-双(羟甲基)丙酯 |
26347-98-8 |
详细
|
| HIF-1 inhibitor-4 |
WAY-299838 |
333357-56-5 |
详细
|
| CP-289503 |
化合物CP-289 |
1349637-14-4 |
详细
|
| p38α inhibitor 3 |
WAY-313218 |
260428-69-1 |
详细
|
| Nampt activator-1 |
|
701929-65-9 |
详细
|
| C3a receptor agonist 1 |
2-环己基-2-苯基-N-[1-(3-吡啶-3-基丙酰基)哌啶-4-基]乙酰胺 |
944997-60-8 |
详细
|
| DC-TEADin02 |
化合物DC-TEADIN02 |
2380228-45-3 |
详细
|
| Todralazine hydrochloride |
盐酸托屈嗪 |
3778-76-5 |
详细
|
| hMAO-B-IN-4 |
|
1666119-75-0 |
详细
|
| UPGL00004 |
UPGL00004 |
1890169-95-5 |
详细
|
| Olaparib Impurity |
奥拉帕尼杂质 |
2415448-60-9 |
详细
|
| (Rac)-Brassinazole |
3-(4-氯苯基)-1-甲基-1-苯基-2-(1,2,4-三唑-1-基)-1-丙醇 |
224047-41-0 |
详细
|
| BYK 191023 dihydrochloride |
BYK191023二盐酸盐 |
1216722-25-6 |
详细
|
| ALW-II-49-7 |
|
1135219-23-6 |
详细
|
| MPT0B014 |
B014 |
1215208-59-5 |
详细
|
| Imiquimod Impurity |
咪喹莫特杂质 |
99010-41-0 |
详细
|
| BRD4 Inhibitor-20 |
化合物 BRD4 INHIBITOR-20 |
2490311-14-1 |
详细
|
| TH34 |
CS-2858 |
2196203-96-8 |
详细
|
| HCV-IN-31 |
Adenosine, 2-amino-2'-deoxy-2'-fluoro-N,2'-dimethyl-, (2'R)- |
1998705-62-6 |
详细
|
| SG-094 |
SG094 |
2922283-37-0 |
详细
|
| LP-471756 |
化合物 T27850 |
413605-11-5 |
详细
|
| CP-447697 |
4-[(苯并[B]噻吩-3-基羰基)[2-(4-氯苯基)乙基]氨基]-N-(2,4-二氟苯基)-1-哌啶甲酰胺 |
1092847-21-6 |
详细
|
| NLRP3-IN-10 |
化合物 NLRP3-IN-10 |
2641826-39-1 |
详细
|
| ROCK-IN-5 |
2-(2-氯-6-氟苯基)-N-(4-(吡啶-4-基)噻唑-2-基)乙酰胺 |
692870-25-0 |
详细
|
| RG 14620 |
TYRPHOSTIN RG 14620 |
136831-49-7 |
详细
|
| GDC-6036 |
GDC6036 |
2417987-45-0 |
详细
|
| ARV-766 |
4-(4-((1-(4-((反式-3-(4-氰基-3-甲氧基苯氧基)-2,2,4,4-四甲基环丁基)氨基甲Chemicalbook酰基)苯基)哌啶-4-基)甲基)哌嗪-1-基)-N-((S)-2,6-二氧代嘧啶-3-基)-2-氟苯甲酰胺 |
2750830-09-0 |
详细
|
| LeterMovir-008-R |
莱特莫韦杂质 |
917389-34-5 |
详细
|
| LeterMovir-013 |
莱特莫韦杂质 |
917389-37-8 |
详细
|
| CNX-1351 |
CNX1351 |
1276105-89-5 |
详细
|
| 2-Propenoic acid, 3-[3-fluoro-2-[[[4-(3-methoxyphenyl)-1-piperazinyl][[2-methoxy-5-(trifluoromethyl)phenyl]imino]methyl]amino]phenyl]-, methyl ester, (2E)- |
莱特莫韦杂质 |
1791412-04-8 |
详细
|
| dTRIM24 |
dTRIM24 |
2170695-14-2 |
详细
|
| TH-Z93 |
|
2260887-09-8 |
详细
|
| 917389-35-6 |
来特莫韦杂质 |
917389-35-6 |
详细
|
| BOS318 |
化合物BOS-318 |
2387633-15-8 |
详细
|
| Letermovir Impurity |
1,3-双(2-甲氧基-5-(三氟甲基)苯基)脲 |
6064-14-8 |
详细
|
| CA-4948 |
CA-4948 |
1801343-74-7 |
详细
|
| BMS-P5 |
BMS-P5 |
1550371-22-6 |
详细
|
| 2-(2,6-dichloro-3,5-dimethoxyphenyl)acetonitrile |
2-(2,6-二氯-3,5-二甲氧基苯基)乙腈 |
869882-16-6 |
详细
|
| VH032 |
VH-032 |
1448188-62-2 |
详细
|
| TD-106 |
TD-106 |
2250288-69-6 |
详细
|
| Gsk484 hydrochloride |
CS-2265 |
1652591-81-5 |
详细
|
| THAL-SNS-032 |
THAL-SNS-032 |
2139287-33-3 |
详细
|
| BI-2865 |
(4S)-2-氨基-4,5,6,7-四氢-4-甲基-4-[3-[4-[(1S)-1-[(2S)-1-甲基-2-吡咯烷基]乙氧基]-2-嘧啶基]-1,2,4-恶二唑-5-基]苯并[b]噻吩-3-甲腈 |
2937327-93-8 |
详细
|
| (S)-Remoxipride Hydrochloride |
瑞莫必利盐酸盐 |
73220-03-8 |
详细
|
| Laninamivir |
拉尼米韦 |
203120-17-6 |
详细
|
| DBRD9 |
DBRD9 |
2170679-45-3 |
详细
|
| GSK215 |
GSK215 |
2743427-26-9 |
详细
|
| SLX-4090 |
913541-47-6 |
913541-47-6 |
详细
|
| Letermovir Impurity |
917389-29-8 |
917389-29-8 |
详细
|
| ASTX660 |
ASTX660 |
1799328-86-1 |
详细
|
| Buspirone Impurity |
丁螺环酮杂质 |
2726492-72-2 |
详细
|
| RBM013209 |
RBN013209 |
2597933-17-8 |
详细
|
| 2(1H)-Pyridinone,4-hydroxy-5-methyl-(9CI) |
非奈利酮杂质 |
41935-71-1 |
详细
|
| SCH529074 |
SCH 529074 |
922150-11-6 |
详细
|
| RN-18 |
431980-38-0 |
431980-38-0 |
详细
|
| VB-124 |
VB-124 |
2230186-18-0 |
详细
|
| SAR407899 |
6-(4-哌啶基氧基)-1(2H)-异喹啉酮 |
923359-38-0 |
详细
|
| MJN110 |
2,5-二氧吡咯烷-1-基4-(双(4-氯苯基)甲基)哌嗪-1-羧酸酯 |
1438416-21-7 |
详细
|
| C-DIM 12 |
C-DIM12 |
178946-89-9 |
详细
|
| INS3-54A18 |
3-(4-氯亚苄基)-1-(4-羟苯基)-5-苯基-1H-吡咯-2(3H)-酮 |
328998-53-4 |
详细
|
| ASP7663 |
ASP 7663;ASP-7663;ASP7663 |
1190217-35-6 |
详细
|
| 1-(2-(3-formyl-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
1-(2-(3-甲酰基-N-甲基苯甲酰氨基)乙基)哌啶-4-基[1,1'-联苯]-2-基氨基甲酸酯 |
864760-28-1 |
详细
|
| PIP-199 |
PIP-199 |
622795-76-0 |
详细
|
| NS 398 |
N-[2-(环己氧基)-4-硝基苯基]甲基磺酰胺 |
123653-11-2 |
详细
|
| CGP-53716 |
N-(4-甲基-3-((4-(吡啶-3-基)嘧啶-2-基)氨基)苯基)苯甲酰胺 |
152459-94-4 |
详细
|
| ST034307 |
6-氯-2-(三氯甲基)-4H-苯并吡喃-4-酮 |
133406-29-8 |
详细
|
| R-10015 |
2-(1-(5-氯-7H-吡咯并[2,3-D]嘧啶-4-基)哌啶-4-基)-1H-苯并[D]咪唑-6-羧酸甲酯 |
2097938-51-5 |
详细
|
| BM635 |
BM635 |
1493762-74-5 |
详细
|
| Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with methyl (4S)-8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4-quinazolineacetate (1:1) |
莱特莫韦杂质 |
917389-30-1 |
详细
|
| NITD-349 |
N-(4,4-二甲基环己基)-4,6-二氟-1H-吲哚-2-甲酰胺 |
1473450-62-2 |
详细
|
| UPF1069 |
5-(2-氧代-2-苯基乙氧基)-1(2H)-异喹啉酮 |
1048371-03-4 |
详细
|
| VK-II-36 |
化合物VK-II-43 |
955371-66-1 |
详细
|
| CB-7921220 |
6-(4-氨基苯乙烯基)吡啶-2-羧酸 |
115453-99-1 |
详细
|
| EB-3D |
1,1'-(((乙烷-1,2-二基双(氧基))双(4,1-亚苯基))双(亚甲基))双(4-(二甲氨基)吡啶-1-鎓)溴化物 |
1839150-63-8 |
详细
|
| ML67-33 |
ML67-33 |
1443290-89-8 |
详细
|
| Atopaxar Hydrobromide |
2-(5,6-二乙氧基-7-氟-1,3-二氢-1-亚氨基-2H-异吲哚-2-基)-1-[3-叔丁基-4-甲氧基-5-(4-吗啉基)苯基]乙酮 |
751475-53-3 |
详细
|
| ML402 |
298684-44-3 |
298684-44-3 |
详细
|
| AF40431 |
AF40431 |
181125-92-8 |
详细
|
| BM212 |
1-((1,5-二(4-氯苯基)-2-甲基-1H-吡咯-3-基)甲基)-4-甲基哌嗪 |
146204-42-4 |
详细
|
| NE-100 hydrochloride |
N,N-二乙基-2-(4-甲氧基-3-苯乙基氧基苯基)乙胺盐酸盐 |
149409-57-4 |
详细
|
| Eprotirome |
3-((3,5-二溴-4-(4-羟基-3-异丙基苯氧基)苯基)氨基)-3-氧代丙酸 |
355129-15-6 |
详细
|
| MSDC-0602 |
5-(4-(2-(3-甲氧基苯基)-2-氧代乙氧基)苄基)噻唑烷-2,4-二酮 |
1133819-87-0 |
详细
|
| KY1220 |
5-((1-(4-硝基苯基)-1H-吡咯-2-基)亚甲基)-2-硫代咪唑烷-4-酮 |
292168-79-7 |
详细
|
| NAcM-OPT |
化合物NACM-OPT |
2089293-61-6 |
详细
|
| Y06036 |
5-溴-2-甲氧基-N-(6-甲氧基-3-甲基苯并[d]异恶唑-5-基)苯磺酰胺 |
1832671-96-1 |
详细
|
| Loreclezole |
(Z)-1-(2-氯-2-(2,4-二氯苯基)乙烯基)-1H-1,2,4-三唑 |
117857-45-1 |
详细
|
| 4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-4-oxido-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, (4S)- |
来特莫韦杂质 |
2991059-71-1 |
详细
|
| Picotamide |
吡考胺 |
32828-81-2 |
详细
|
| Nomifensine maleate |
诺米芬新马来酸盐 |
32795-47-4 |
详细
|
| Auten-99 HBr |
2-([1,1'-联苯]-4-基)-5,6-二氢咪唑并[2,1-b]噻唑氢溴酸盐 |
1049780-58-6 |
详细
|
| AU1235 |
1338780-86-1 |
1338780-86-1 |
详细
|
| C-215 |
N-[(2,4-dichlorophenyl)methyl]-1-propylbenzimidazol-5-amine |
912780-51-9 |
详细
|
| 2-Pyrazinecarbonitrile, 6-ethyl-3-[[3-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[(tetrahydro-2H-pyran-4-yl)amino]- |
吉列替尼N-1 |
2043019-99-2 |
详细
|
| FK-3311 |
N-[4-乙酰基-2-(2,4-二氟苯氧基)苯基]-甲烷磺酰胺 |
116686-15-8 |
详细
|
| A 438079 hydrochloride |
3-[[5-(2,3-二氯苯基)-1H-四唑-1-基]甲基]吡啶单盐酸盐 |
899431-18-6 |
详细
|
| GSK3359088 |
GSK 3359088 |
1628830-21-6 |
详细
|